BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Digital Artificial Intelligence

Bridging Real-World Evidence and AI: Unlocking Smarter, Faster Clinical Research in Asia

Having worked with pharma clients, healthcare providers, and digital platforms across the Asia-Pacific region, I’ve seen the challenges first-hand&md...

August 04, 2025 | Opinion

Nebius Is Accelerating Drug Discovery with AI Infrastructure That Slashes Timelines from Years to Months

The traditional 7–10-year timeline for drug discovery is rapidly becoming obsolete. Thanks to advances in AI and compute infrastructure, pioneers lik...

August 04, 2025 | Interview

Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery

Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...

August 04, 2025 | News

Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery

Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...

August 04, 2025 | News

Revival Healthcare Capital and Olympus Launch $458M Joint Venture to Advance GI Robotics Innovation

Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a st...

July 28, 2025 | News

iMedX Gains Health NZ Endorsement for AI Scribe Trial Across Public Health Services

iMedX is proud to announce its formal endorsement by Health New Zealand | Te Whatu Ora as one of only two Ambient AI Scribe tools approved for trialling wi...

July 24, 2025 | News

Smart Implants and the Future of Musculoskeletal Injury Treatment

While these methods are structurally effective, they cannot adapt to each patient's recovery process or provide insight into the progression of healing. Th...

July 21, 2025 | News

Fangzhou and Novo Nordisk Forge Strategic Alliance to Revolutionise Chronic Disease Management with AI

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, ...

July 21, 2025 | News

Fujitsu and Acer Medical to Launch AI-Powered Gait Analysis for Early Dementia and Parkinson’s Detection in Taiwan

Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to dev...

July 16, 2025 | News

BioMed X and Servier Launch Europe’s First XSeed Labs at Paris-Saclay to Accelerate AI-Driven Bispecific Antibody Design

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced the launch of a new initiative with Se...

July 10, 2025 | News

Smarter Together: How Molecule GEN Transforms Cross-Functional Drug Discovery

This cloud-native, SaaS-based platform breaks down traditional barriers in drug discovery by uniting all disciplines—biology, chemistry, and computat...

July 07, 2025 | Opinion | By Saurabh Singal | CEO-Founder, Molecule AI

Lunit Partners with Microsoft to Scale AI-Powered Cancer Diagnostics Globally

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, announced a collaboration with Microsoft to accelerate the deliver...

July 03, 2025 | News

Sartorius Finalises Acquisition of MatTek and Visikol to Bolster Cell Technology Portfolio

The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO ...

July 03, 2025 | News

Seegene Launches STAgora™ to Deliver Real-Time Infectious Disease Intelligence and Predictive Insights

Real-time analytics that empower clinical decision-making and pandemic preparedness Global unveiling at ADLM 2025 in Chicago to initiate business p...

July 02, 2025 | News

Stay Connected